4//SEC Filing
AILERON THERAPEUTICS INC 4
Accession 0000899243-17-017605
$RNTXCIK 0001420565operating
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 1:32 PM ET
Size
5.4 KB
Accession
0000899243-17-017605
Insider Transaction Report
Form 4
Dougherty Donald
SVP & Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-06-28+140,887→ 140,887 totalExercise: $15.00Exp: 2027-06-28→ Common Stock (140,887 underlying)
Footnotes (1)
- [F1]These options were granted on June 28, 2017 and vest as to 25% of the shares on June 8, 2018 and vest thereafter as to 2.0833% of the shares in equal monthly installments through June 8, 2021.
Documents
Issuer
AILERON THERAPEUTICS INC
CIK 0001420565
Entity typeoperating
Related Parties
1- filerCIK 0001420565
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 1:32 PM ET
- Size
- 5.4 KB